Brookfield Corp’s CDK Global, Inc. CDK Stock Holding History

Brookfield Corp’s Portfolio CDK Stock Details CDK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-183,800	Closed	-$8.95M	–	780
2022 Q1	$8.95M	Buy	+183,800	New	+$8.22M	0.03%	169

Other funds holding CDK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.18B AUM 0.37% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brookfield Corp's CDK Position: Q2 2022 in Review

Brookfield Corp sold out of CDK Global, Inc. (CDK) in Q2 2022, closing a stake of 183,800 shares — an estimated $8.95M sold.

Brookfield Corp first reported a position in CDK in Q1 2022 and held it in 1 quarter. The position peaked at $8.95M in Q1 2022. 455 funds tracked by Wall St. Rank hold CDK as of Q2 2022.

Brookfield Corp reported no remaining CDK Global, Inc. position as of Q2 2022 after selling out during the quarter.
Brookfield Corp sold 183,800 CDK Global, Inc. shares in Q2 2022, an estimated $8.95M.
Brookfield Corp first reported a position in CDK Global, Inc. in Q1 2022 and held it in 1 quarter.
Brookfield Corp's CDK Global, Inc. position peaked at $8.95M in Q1 2022.
455 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q2 2022.

Based on Brookfield Corp's 13F filing for Q2 2022, filed 15 Aug 2022.